Variant report

Variant	nsv1050121
Chromosome Location	chr11:26532655-26675303
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1211)
CpG islands
(count:427)
Chromatin interactive
region (count:11)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1211 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr11:26671444-26671614	K562	blood:	n/a	n/a
2	ATF1	chr11:26644736-26644808	K562	blood:	n/a	n/a
3	ATF2	chr11:26654088-26654778	GM12878	blood:	n/a	n/a
4	ATF2	chr11:26544464-26545008	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr11:26654070-26654702	GM12878	blood:	n/a	n/a
6	ATF2	chr11:26629236-26629961	GM12878	blood:	n/a	n/a
7	ATF2	chr11:26629324-26629821	GM12878	blood:	n/a	n/a
8	BATF	chr11:26644625-26644850	GM12878	blood:	n/a	chr11:26644777-26644787
9	BATF	chr11:26629279-26629906	GM12878	blood:	n/a	n/a
10	BATF	chr11:26654375-26654648	GM12878	blood:	n/a	n/a
11	BATF	chr11:26644564-26644856	GM12878	blood:	n/a	chr11:26644777-26644787
12	BCL11A	chr11:26654235-26654678	GM12878	blood:	n/a	n/a
13	BCL11A	chr11:26629487-26629695	GM12878	blood:	n/a	n/a
14	BCL11A	chr11:26629435-26629822	GM12878	blood:	n/a	n/a
15	BHLHE40	chr11:26673393-26673826	GM12878	blood:	n/a	n/a
16	BHLHE40	chr11:26671338-26671661	GM12878	blood:	n/a	n/a
17	BHLHE40	chr11:26654159-26654713	GM12878	blood:	n/a	n/a
18	BHLHE40	chr11:26637164-26637178	GM12878	blood:	n/a	n/a
19	BHLHE40	chr11:26593452-26593724	GM12878	blood:	n/a	n/a
20	BHLHE40	chr11:26671480-26671680	K562	blood:	n/a	n/a
21	BHLHE40	chr11:26629582-26630703	GM12878	blood:	n/a	n/a
22	BHLHE40	chr11:26573138-26573273	GM12878	blood:	n/a	n/a
23	BRCA1	chr11:26544501-26545118	H1-hESC	embryonic stem cell:	n/a	n/a
24	BRCA1	chr11:26629866-26629936	GM12878	blood:	n/a	n/a
25	BRCA1	chr11:26671378-26671648	Hela-S3	cervix:	n/a	n/a
26	CEBPB	chr11:26621019-26621383	Hela-S3	cervix:	n/a	chr11:26621231-26621242
27	CEBPB	chr11:26625389-26625685	Hela-S3	cervix:	n/a	n/a
28	CEBPB	chr11:26611345-26611681	HepG2	liver:	n/a	n/a
29	CEBPB	chr11:26581593-26581864	A549	lung:	n/a	chr11:26581747-26581758
30	CEBPB	chr11:26619512-26619802	IMR90	lung:	n/a	chr11:26619645-26619656 chr11:26619643-26619654
31	CEBPB	chr11:26579768-26580050	ECC-1	luminal epithelium:	n/a	n/a
32	CEBPB	chr11:26581660-26581852	Hela-S3	cervix:	n/a	chr11:26581747-26581758
33	CEBPB	chr11:26605110-26605438	HepG2	liver:	n/a	chr11:26605215-26605226 chr11:26605270-26605281
34	CEBPB	chr11:26595593-26595864	HepG2	liver:	n/a	n/a
35	CEBPB	chr11:26621018-26621383	A549	lung:	n/a	chr11:26621231-26621242
36	CEBPB	chr11:26642654-26643019	Hela-S3	cervix:	n/a	n/a
37	CEBPB	chr11:26595644-26595769	A549	lung:	n/a	n/a
38	CEBPB	chr11:26636744-26637059	HepG2	liver:	n/a	n/a
39	CEBPB	chr11:26589040-26589152	A549	lung:	n/a	n/a
40	CEBPB	chr11:26595511-26595872	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr11:26597137-26597408	IMR90	lung:	n/a	chr11:26597230-26597241
42	CEBPB	chr11:26621046-26621332	HepG2	liver:	n/a	chr11:26621231-26621242
43	CEBPB	chr11:26597168-26597409	A549	lung:	n/a	chr11:26597230-26597241
44	CEBPB	chr11:26555262-26555494	HepG2	liver:	n/a	n/a
45	CEBPB	chr11:26597092-26597408	K562	blood:	n/a	chr11:26597230-26597241
46	CEBPB	chr11:26604992-26605507	ECC-1	luminal epithelium:	n/a	chr11:26605215-26605226 chr11:26605270-26605281
47	CEBPB	chr11:26604880-26605618	MCF-7	breast:	n/a	chr11:26605215-26605226 chr11:26605270-26605281
48	CEBPB	chr11:26644700-26645139	Hela-S3	cervix:	n/a	chr11:26645011-26645024 chr11:26645012-26645023
49	CEBPB	chr11:26625453-26625642	IMR90	lung:	n/a	n/a
50	CEBPB	chr11:26636897-26636936	H1-hESC	embryonic stem cell:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:26593556-26593606	HRCEpiC	kidney:	n/a
2	chr11:26594620-26594670	HAEpiC	amniotic membrane:	n/a
3	chr11:26593658-26593708	AG10803	skin:	n/a
4	chr11:26594782-26594832	SK-N-SH	brain:	n/a
5	chr11:26594620-26594670	RPTEC	kidney:	n/a
6	chr11:26594782-26594832	AG10803	skin:	n/a
7	chr11:26594782-26594832	HUVEC	blood vessel:	n/a
8	chr11:26581996-26582046	HIPEpiC	eye:	n/a
9	chr11:26594782-26594832	U87	brain:	n/a
10	chr11:26593881-26593931	HIPEpiC	eye:	n/a
11	chr11:26594782-26594832	K562	blood:	n/a
12	chr11:26581996-26582046	AoSMC	blood vessel:	n/a
13	chr11:26581996-26582046	NT2-D1	testis:	n/a
14	chr11:26594782-26594832	NHBE	bronchial:	n/a
15	chr11:26593658-26593708	PFSK-1	brain:	n/a
16	chr11:26594782-26594832	RPTEC	kidney:	n/a
17	chr11:26594782-26594832	HRPEpiC	eye:	n/a
18	chr11:26581996-26582046	Caco-2	colon:	n/a
19	chr11:26593658-26593708	ECC-1	luminal epithelium:	n/a
20	chr11:26581996-26582046	NH-A	brain:	n/a
21	chr11:26593556-26593606	ProgFib	skin:	n/a
22	chr11:26593881-26593931	HAEpiC	amniotic membrane:	n/a
23	chr11:26593556-26593606	HEK293	kidney:	embryo
24	chr11:26544953-26545003	HEEpiC	esophagus:	n/a
25	chr11:26593881-26593931	HCPEpiC	choroid plexus:	n/a
26	chr11:26581996-26582046	PANC-1	pancreas:	n/a
27	chr11:26544953-26545003	NT2-D1	testis:	n/a
28	chr11:26544953-26545003	Hepatocyte	liver:	n/a
29	chr11:26593658-26593708	AG09319	gingival:	n/a
30	chr11:26594620-26594670	Hela-S3	cervix:	n/a
31	chr11:26593658-26593708	HCF	heart:	n/a
32	chr11:26593881-26593931	Jurkat	blood:	n/a
33	chr11:26593881-26593931	GM12892	blood:	n/a
34	chr11:26593658-26593708	SK-N-SH_RA	brain:	n/a
35	chr11:26581996-26582046	K562	blood:	n/a
36	chr11:26594620-26594670	AG10803	skin:	n/a
37	chr11:26594620-26594670	HCT-116	colon:	n/a
38	chr11:26593881-26593931	HRPEpiC	eye:	n/a
39	chr11:26594782-26594832	GM19239	blood:	n/a
40	chr11:26594782-26594832	Hepatocyte	liver:	n/a
41	chr11:26581996-26582046	HCF	heart:	n/a
42	chr11:26544953-26545003	PANC-1	pancreas:	n/a
43	chr11:26594782-26594832	MCF10A-Er-Src	breast:	n/a
44	chr11:26593658-26593708	PrEC	prostate:	n/a
45	chr11:26593556-26593606	AG04449	skin:	fetal
46	chr11:26594782-26594832	SK-N-MC	brain:	n/a
47	chr11:26594782-26594832	HRCEpiC	kidney:	n/a
48	chr11:26594620-26594670	BE2_C	brain:	n/a
49	chr11:26544953-26545003	T-47D	breast:	n/a
50	chr11:26593556-26593606	HAEpiC	amniotic membrane:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:26629270..26631902-chr11:26633613..26635854,2	K562	blood:
2	chr11:26318636..26319225-chr11:26543911..26544770,2	MCF-7	breast:
3	chr11:26586123..26588285-chr11:26619056..26621228,2	K562	blood:
4	chr11:26669136..26671365-chr14:104584975..104586845,2	MCF-7	breast:
5	chr11:26318438..26319350-chr11:26670793..26671982,7	MCF-7	breast:
6	chr11:26629270..26631902-chr11:26633613..26635854,2	K562	blood:
7	chr11:26586123..26588285-chr11:26619056..26621228,2	K562	blood:
8	chr11:26594478..26596618-chr11:26598306..26601067,2	MCF-7	breast:
9	chr11:26544159..26545613-chr11:26671003..26672359,7	MCF-7	breast:
10	chr11:26594478..26596618-chr11:26598306..26601067,2	MCF-7	breast:
11	chr11:26544159..26545613-chr11:26671003..26672359,7	MCF-7	breast:

No data

Variant related genes	Relation type
MUC15	TF binding region
ANO3	TF binding region
MUC15	CpG island
ANO3	CpG island

Extended variants
information (count: 5752 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:5752 , 50 per page) page: 1 2 3 4 5 6 7 ... 116

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs117402738	chr11:26532672-26532673	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs534922337	chr11:26532688-26532689	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs375136643	chr11:26532771-26532772	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs561455076	chr11:26532786-26532787	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs117823677	chr11:26532818-26532819	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs137973183	chr11:26532841-26532842	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs56070600	chr11:26532851-26532852	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs371536397	chr11:26532853-26532854	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs113958511	chr11:26532902-26532903	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs142506829	chr11:26532975-26532976	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs12290955	chr11:26532976-26532977	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs12284101	chr11:26533032-26533033	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs567534313	chr11:26533039-26533040	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs57660147	chr11:26533043-26533044	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs149487243	chr11:26533112-26533113	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs534638499	chr11:26533140-26533141	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs143856782	chr11:26533167-26533168	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs117808631	chr11:26533191-26533192	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs190083563	chr11:26533215-26533216	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs572487894	chr11:26533252-26533253	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs113379291	chr11:26533326-26533327	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs553663285	chr11:26533337-26533338	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs565706666	chr11:26533378-26533379	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs117554013	chr11:26533395-26533396	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs554749132	chr11:26533407-26533408	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs77397516	chr11:26533453-26533454	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs77545197	chr11:26533457-26533458	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs377351337	chr11:26533465-26533466	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs543980136	chr11:26533473-26533474	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs140298168	chr11:26533534-26533535	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs180978419	chr11:26533542-26533543	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs117257643	chr11:26533547-26533548	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs17243357	chr11:26533558-26533559	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs553202118	chr11:26533573-26533574	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs542451538	chr11:26533595-26533596	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs185006148	chr11:26533614-26533615	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs531392803	chr11:26533627-26533628	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs116900912	chr11:26533644-26533645	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs373891453	chr11:26533650-26533651	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs190931514	chr11:26533680-26533681	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs376469078	chr11:26533688-26533689	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs532000783	chr11:26533702-26533703	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs144246741	chr11:26533727-26533728	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs565998676	chr11:26533729-26533730	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs114375196	chr11:26533737-26533738	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs183956344	chr11:26533776-26533777	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs569760543	chr11:26533781-26533782	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs187225364	chr11:26533789-26533790	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs367808001	chr11:26533875-26533876	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs147535950	chr11:26533889-26533890	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Renal cell carcinoma	18194544	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Autism	22102821	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Neuroticism	17667963	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Ependymoma	20639864	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:302 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:26506400-26564600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
2	chr11:26531200-26533800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr11:26532400-26534000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr11:26532600-26533600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
5	chr11:26533800-26534000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr11:26533800-26540800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr11:26540800-26542000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr11:26540800-26543200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr11:26541000-26542000	Enhancers	Adipose Nuclei	Adipose
10	chr11:26544400-26545200	Active TSS	HUES64 Cell Line	embryonic stem cell
11	chr11:26544400-26545200	Active TSS	iPS-18 Cell Line	embryonic stem cell
12	chr11:26544400-26545400	Active TSS	HUES6 Cell Line	embryonic stem cell
13	chr11:26544400-26545600	Active TSS	HUES48 Cell Line	embryonic stem cell
14	chr11:26544600-26545000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr11:26544600-26545200	Active TSS	ES-I3 Cell Line	embryonic stem cell
16	chr11:26544600-26545200	Active TSS	ES-WA7 Cell Line	embryonic stem cell
17	chr11:26544600-26545200	Active TSS	H9 Cell Line	embryonic stem cell
18	chr11:26544600-26545400	Active TSS	iPS-15b Cell Line	embryonic stem cell
19	chr11:26544600-26545400	Active TSS	iPS-20b Cell Line	embryonic stem cell
20	chr11:26544800-26545200	Active TSS	H1 Cell Line	embryonic stem cell
21	chr11:26544800-26545200	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr11:26545200-26545400	Enhancers	HUES64 Cell Line	embryonic stem cell
23	chr11:26545200-26545400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
24	chr11:26545400-26545600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
25	chr11:26545400-26545600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
26	chr11:26545400-26545800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
27	chr11:26545400-26546000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
28	chr11:26545400-26546400	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
29	chr11:26545600-26545800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
30	chr11:26545600-26545800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
31	chr11:26545600-26545800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
32	chr11:26545600-26546200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
33	chr11:26546400-26546600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
34	chr11:26558800-26559400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr11:26564600-26565000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr11:26565000-26599200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr11:26570200-26570600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
38	chr11:26570800-26571400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr11:26571400-26572400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr11:26572600-26572800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr11:26578000-26578600	Enhancers	Stomach Mucosa	stomach
42	chr11:26578200-26578600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr11:26579200-26580600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr11:26579600-26580000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr11:26579800-26592600	Weak transcription	Placenta	Placenta
46	chr11:26580000-26580200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
47	chr11:26590400-26590800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr11:26590800-26591000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
49	chr11:26590800-26591000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr11:26590800-26591600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links